11-9853539-C-T
Variant summary
Our verdict is Pathogenic. The variant received 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_030962.4(SBF2):c.2536+1G>A variant causes a splice donor, intron change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000479 in 1,460,952 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Consequence
NM_030962.4 splice_donor, intron
Scores
Clinical Significance
Conservation
Publications
- Charcot-Marie-Tooth disease type 4B2Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), G2P, ClinGen, Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 12 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 0.00000479 AC: 7AN: 1460952Hom.: 0 Cov.: 31 AF XY: 0.00000550 AC XY: 4AN XY: 726802 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Charcot-Marie-Tooth disease type 4 Pathogenic:1
For these reasons, this variant has been classified as Pathogenic. Donor and acceptor splice site variants are typically truncating (PMID: 16199547), and truncating variants in SBF2 are known to be pathogenic (PMID: 15304601).This particular variant has been reported in the literature in an individual affected with Charcot-Marie-Tooth disease (CMT) type 1 (PMID: 26392352) and in an individual affected with CMT in the Invitae database. This sequence change affects a donor splice site in intron 20 of the SBF2 gene. It is expected to disrupt mRNA splicing and likely results in an absent or disrupted protein product. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at